Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) as secondline therapy for patients with advanced urothelial cancer

There is currently no standard treatment for metastatic urothelial cancer after failure of cisplatin-based therapy. The present retrospective study investigated the efficacy and safety of oxaliplatin plus 5-fluorouracil (5-FU) and leucovorin (LV) (FOLFOX) in locally advanced or metastatic urothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sheng, Xue, Hongxi, Chen, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295454/
https://www.ncbi.nlm.nih.gov/pubmed/27409828
http://dx.doi.org/10.18632/oncotarget.10463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295454/
https://www.ncbi.nlm.nih.gov/pubmed/27409828
http://dx.doi.org/10.18632/oncotarget.10463

Ejemplares similares